Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Analysts are Downgrading These 5 Stocks

In this article, we discuss the 5 stocks receiving downgrades from analysts. If you want to see some more companies whose ratings were recently cut by analysts, go directly to Analysts are Downgrading These 10 Stocks.  

5. L3Harris Technologies, Inc. (NYSE:LHX)

Number of Hedge Fund Holders: 34

L3Harris Technologies, Inc. (NYSE:LHX) specializes in aerospace and defense technology. It designs and manufactures a range of radio communications products and systems. It is also famous for its advanced defense and commercial technologies for various industries.

The Florida-based company recently received a downgrade from BofA. The research firm lowered its ratings for L3Harris Technologies, Inc. (NYSE:LHX) from “Buy” to “Neutral” on Friday, November 11.

BofA Ronald Epstein thinks supply-chain headwinds will impact the growth of L3Harris Technologies, Inc. (NYSE:LHX). Epstein expects supply challenges to persist into 2024. He also cut his price target for the stock from $285 per share to $250 per share.

Follow L3Harris Technologies Inc. (NYSE:LHX)

4. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Holders: 35

JPMorgan turned bearish on Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, November 14. The research firm cut its ratings for the Israeli pharmaceutical company from “Neutral” to “Underweight,” citing persistent growth hurdles.

Referring to the third-quarter report, analyst Christopher Schott said the results once again showed that Teva Pharmaceutical Industries Limited (NYSE:TEVA) continues to face challenges due to the absence of a growth catalyst in its portfolio.

Earlier this month, Teva Pharmaceutical Industries Limited (NYSE:TEVA) posted weak financial results for Q3. The company earned 59 cents per share on an adjusted basis, unchanged from the year-ago period and below the consensus of 62 cents per share. Revenue for the quarter fell 8 percent versus last year to $3.59 billion, while analysts were looking for $3.83 billion

Moreover, Teva Pharmaceutical Industries Limited (NYSE:TEVA) also cut its fiscal 2022 sales outlook to a range of $14.8 – $15.4 billion. The revised guidance is below analysts’ average estimate of $15.46 billion.

Follow Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

3. Tyson Foods, Inc. (NYSE:TSN)

Number of Hedge Fund Holders: 37

BofA lowered its ratings for Tyson Foods, Inc. (NYSE:TSN) from “Neutral” to “Underperform” on Wednesday, November 9. Analyst Peter Galbo was primarily moved by deteriorating macro factors and decreasing chicken prices.

Galbo expects beef margins to drop further through 2024. He also cut his price target for Tyson Foods, Inc. (NYSE:TSN) from $73 per share to $61 per share.

Meanwhile, Tyson Foods, Inc. (NYSE:TSN) delivered mixed financial results for its fiscal fourth quarter on Monday, November 14. The processed meat producer reported adjusted earnings of $1.63 per share, down from $2.30 per share in the same period of 2021. Revenue came in at $13.74 billion, up 7.2 percent on a year-over-year basis. Analysts were looking for earnings of $1.70 per share on revenue of $13.49 billion.

Follow Tyson Foods Inc. (NYSE:TSN)

2. Freeport-McMoRan Inc. (NYSE:FCX)

Number of Hedge Fund Holders: 56

Scotiabank trimmed its ratings for Freeport-McMoRan Inc. (NYSE:FCX) from “Outperform” to “Sector Perform” on Friday, November 11. Analyst Orest Wowkodaw mentioned a range of factors that could impact copper prices this year.

The factors putting downward pressure on the prices include rising interest rates, elevated energy costs, a strong U.S. dollar, Covid restrictions in China and geopolitical uncertainty amid the Russia-Ukraine war.

Separately, investment management firm ClearBridge Investments also discussed Freeport-McMoRan Inc. (NYSE:FCX) in its third-quarter 2022 investor letter, stating:

“Seeing better opportunities elsewhere in the materials sector, we exited our position in Ecolab and added to copper producer Freeport-McMoRan Inc. (NYSE:FCX), which supplies a much-needed resource for the energy transition, and specialty chemical company Linde (LIN), which has historically held onto pricing gains it has achieved following increases in energy costs. We think this pricing power should protect profitability during the acute inflationary phase and potentially lead to margin expansion when cost pressures abate. We think this pricing power should protect profitability during the acute inflationary phase and potentially lead to margin expansion when cost pressures abate.”

Follow Freeport-Mcmoran Inc (NYSE:FCX)

1. Global Payments Inc. (NYSE:GPN)

Number of Hedge Fund Holders: 57

Global Payments Inc. (NYSE:GPN) received a downgrade from Baird on Monday, November 14. The research firm cut its ratings for the Phoenix-based mining company from “Outperform” to “Neutral,” citing the absence of positive catalysts in the near term.

Baird also reduced its price target for Global Payments Inc. (NYSE:GPN) from $114 per share to $118 per share.

Follow Global Payments Inc (NYSE:GPN)

Separately, Global Payments Inc. (NYSE:GPN) also appeared in the second-quarter 2022 investor letter of asset manager Manole Capital Management. Here’s what the firm said:

“Over the next week or so, we will be publishing a stock-specific note on payment processor Global Payments Inc. (NYSE:GPN). We have owned GPN for nearly two decades and it currently is one of our largest positions. We will begin by highlighting recent spending trends, eCommerce developments and how many of our payment companies can actually benefit from inflation and higher costs. We will discuss their business, industry trends, what is driving their growth, and then highlight their compelling valuation.”

You can also take a peek at Steven Boyd and Armistice Capital’s Top Stock Picks and 12 Best Consumer Staple Stocks.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.